Freeport-McMoRan, Inc. vs Linde plc — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
7
Buy
Quality
Health
Growth
Valuation
Sentiment
FCX
Clean balance sheet with low leverage (0.3× debt-to-equity).
LIN
High-quality business with 18% return on equity and 20% profit margins.
⚠ valuation offers limited margin of safety.
Analyst Consensus
BUY
Target $67.90 (+18.3%)
21 analysts
BUY
Target $525.49 (+4.0%)
25 analysts
Fundamentals
FCX
LIN
30.4×
Trailing P/E
34.6×
15.5×
Forward P/E
25.9×
10.3%
Profit Margin
20.3%
37.1%
Gross Margin
48.8%
15.6%
ROE
17.8%
8.8%
Revenue Growth
5.8%
154.0%
Earnings Growth
-9.4%
1.47
Beta
0.79
—
Price / Book
—
$82.4B
Market Cap
$234.0B
$35 – $71
52-Week Range
$388 – $516
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.